STOCK TITAN

Claritev Corporation (CTEV) 10-K Filings

CTEV NYSE

Ticker history: MPLN became CTEV (Claritev Corporation) on . Earlier news and filings retain their original names and dates. View MPLN history.

Here are the 10-K annual reports from Claritev Corporation (CTEV) in our archive since June 2025, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A 10-K covers the audited annual report, with the full financial statements, so if you follow CTEV and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full CTEV filings page.

Rhea-AI Summary

Claritev Corporation describes itself as a technology, data and insights company focused on reducing cost, risk and complexity in the U.S. healthcare system. The company serves more than 750 payer clients and estimates its solutions touch over 60 million consumers through 100,000+ plan sponsors.

Claritev reports identifying $25.0 billion in potential savings on $179.8 billion in claim charges in 2025, leveraging a platform that processes about 30 million claims per month and a proprietary network of over 1.4 million contracted providers. It estimates total addressable markets of roughly $10.0 billion for out-of-network cost management, $3.0 billion for in‑network payment and revenue integrity, and $17.0 billion for newer analytics and transparency offerings.

The report outlines the Vision 2030 strategy and notes 2025 was branded “THE TURN,” marking a return to year‑over‑year revenue growth, with 2026 branded “THE WAY UP.” Key risks include dependence on a few large clients, high leverage, intense competition, extensive healthcare regulation and cybersecurity and data‑privacy exposure. As of June 30 2025, non‑affiliate market value was about $505.8 million, and as of February 23 2026, 16,552,723 Class A shares were outstanding.